• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On January 7th, Zhenxin Technology announced that, according to a notice issued by the Military Procurement Network on January 6th, 2026, the Joint Staff Department of the Western Theater Command, in accordance with relevant regulations on military supplier management, has decided to ban Chengdu Guoxing Communication Co., Ltd., a subsidiary of Chengdu Zhenxin Technology Co., Ltd., from participating in material and engineering service procurement activities within the Western Theater Command for three years, effective January 6th, 2026. An investigation confirmed that Guoxing Communication engaged in bid rigging and other irregularities in the procurement activity for project number 2020-ZCWDDK-W1002. Currently, the company and its subsidiarys overall production and operation activities are normal. During the ban period, Guoxing Communication cannot participate in material and engineering service procurement activities within the Western Theater Command (headquarters and directly affiliated units). It is expected that this decision will not have a significant impact on the company and its subsidiarys production and operation at present.Xiaomi Group (01810.HK) repurchased 3.9 million Class B shares for HK$148.8 million on January 7.On January 7th, CIMC Group (02039.HK) announced that it holds a 45.92% stake in Shenzhen CIMC Industrial City Development Group Co., Ltd. through its wholly-owned subsidiary, CIMC Shenfa Construction Industry Co., Ltd. CIMC Industrial City recently sold its entire Qianhai CIMC International Business Center East Tower project for approximately RMB 2.534 billion. Preliminary calculations indicate that this transaction is expected to indirectly reduce CIMC Groups net profit attributable to shareholders in 2025 by approximately RMB 1.08 billion.Tencent Holdings (00700.HK): On January 7, it repurchased 1.023 million shares, costing approximately HK$640 million.On January 7th, Hengrui Medicine announced that its subsidiary, Suzhou Shengdiya Biopharmaceutical Co., Ltd., received notification from the National Medical Products Administration (NMPA) approving the marketing of its independently developed Class 1 innovative drug, Relavop α Injection. This drug, in combination with fluorouracil and platinum-based drugs, is indicated for first-line treatment of PD-L1-positive locally advanced unresectable, recurrent, or metastatic adenocarcinoma of the stomach and gastroesophageal junction, based on well-validated diagnostic criteria. No similar products have been approved for marketing domestically or internationally. To date, the cumulative R&D investment in the Relavop α Injection project has reached approximately RMB 711 million.

The AUD/JPY exchange rate fluctuates below 90.00 as investors await BoJ action

Alina Haynes

Jan 18, 2023 15:03

 AUD:JPY.png

 

In the early Asian session, the AUD/JPY currency pair is bouncing violently in a narrow range below the resistance level of 90.00. Before the Bank of Japan introduces its first monetary policy of CY2023, the risk barometer indicates a sideways auction (BoJ). The AUD/JPY exchange rate reflects the consolidation of the AUD/USD, indicating an uncertain risk profile.

 

Investors anticipate that the Bank of Japan (BoJ) will not alter its policy stance on Friday, as doing so would increase financial market risk and hinder efforts to boost inflation. Previously, the Bank of Japan (BoJ) announced that the central bank will review the negative side effects of the decade-long ultra-loose monetary policy, generating the impression that the central bank is eager to abandon the easy policy.

 

The experts at Standard Charted expect the Bank of Japan to hold both the policy balance rate and the 10-year yield goal at their present levels of -0.1% and 0%, respectively. The recent decision to expand the 10-year JGB band to +/-50 bps (from +/-25 bps) will be evaluated by policymakers at the December meeting.

 

The replacement of current Governor of the Bank of Japan Haruhiko Kuroda will be widely followed. The next BoJ governor nominee is anticipated to be presented to the Japanese parliament on February 10, Reuters reported on Tuesday. Amamiya, Nakaso, and Yamaguchi are regarded as leading C.banking candidates.

 

Thursday is the expected publication date for Australian employment statistics, which investors are monitoring. The Unemployment Rate is expected to remain constant at 3.4%, according to the majority of economists. Aside from this, the Australian economy must have added 22,500 new jobs to the labor market in December, a down from the prior rises of 64K.